Cargando…

Comparative Genomics of Bacteroides fragilis Group Isolates Reveals Species-Dependent Resistance Mechanisms and Validates Clinical Tools for Resistance Prediction

Bacteroides fragilis group (BFG) are the most frequently recovered anaerobic bacteria from human infections, and resistance to frontline antibiotics is emerging. In the absence of routine antimicrobial susceptibility testing (AST) for BFG in most clinical settings, we assessed the utility of clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallace, Miranda J., Jean, Sophonie, Wallace, Meghan A., Burnham, Carey-Ann D., Dantas, Gautam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764542/
https://www.ncbi.nlm.nih.gov/pubmed/35038926
http://dx.doi.org/10.1128/mbio.03603-21
_version_ 1784634190192443392
author Wallace, Miranda J.
Jean, Sophonie
Wallace, Meghan A.
Burnham, Carey-Ann D.
Dantas, Gautam
author_facet Wallace, Miranda J.
Jean, Sophonie
Wallace, Meghan A.
Burnham, Carey-Ann D.
Dantas, Gautam
author_sort Wallace, Miranda J.
collection PubMed
description Bacteroides fragilis group (BFG) are the most frequently recovered anaerobic bacteria from human infections, and resistance to frontline antibiotics is emerging. In the absence of routine antimicrobial susceptibility testing (AST) for BFG in most clinical settings, we assessed the utility of clinical and modern genomics tools to determine BFG species-level identification and resistance patterns. A total of 174 BFG clinical isolates supplemented with 20 archived carbapenem-resistant B. fragilis sensu stricto (BFSS) isolates underwent antimicrobial susceptibility testing, MALDI-ToF mass-spectrometry, and whole-genome sequencing (WGS). Bruker BioTyper and VITEK-MS MALDI-ToF systems demonstrated accurate species-level identifications (91% and 90% agreement, respectively) compared to average nucleotide identity (ANI) analysis of WGS data. Distinct β-lactamase gene profiles were observed between BFSS and non-fragilis Bacteroides species, with significantly higher MICs to piperacillin-tazobactam in B. vulgatus and B. thetaiotaomicron relative to BFSS (P ≤ 0.034). We also uncovered phylogenetic diversity at the genomospecies level between division I and division II BFSS (ANI <0.95) and demonstrate that division II BFSS strains harbor an increased capacity to achieve carbapenem resistance through chromosomal activation of the CfiA carbapenemase. Finally, we report that CfiA detection by the Bruker BioTyper Subtyping Module accurately detected carbapenem resistance in BFSS with positive and negative percent agreement of 94%/90% and 95%/95% compared to ertapenem and meropenem susceptibility, respectively. These comparative analyses indicate that resistance mechanisms are distinct at both the phenotypic and genomic level across species within the BFG and that modern MALDI-ToF identification systems can be used for accurate species-level identification and resistance prediction of the BFG.
format Online
Article
Text
id pubmed-8764542
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-87645422022-01-24 Comparative Genomics of Bacteroides fragilis Group Isolates Reveals Species-Dependent Resistance Mechanisms and Validates Clinical Tools for Resistance Prediction Wallace, Miranda J. Jean, Sophonie Wallace, Meghan A. Burnham, Carey-Ann D. Dantas, Gautam mBio Research Article Bacteroides fragilis group (BFG) are the most frequently recovered anaerobic bacteria from human infections, and resistance to frontline antibiotics is emerging. In the absence of routine antimicrobial susceptibility testing (AST) for BFG in most clinical settings, we assessed the utility of clinical and modern genomics tools to determine BFG species-level identification and resistance patterns. A total of 174 BFG clinical isolates supplemented with 20 archived carbapenem-resistant B. fragilis sensu stricto (BFSS) isolates underwent antimicrobial susceptibility testing, MALDI-ToF mass-spectrometry, and whole-genome sequencing (WGS). Bruker BioTyper and VITEK-MS MALDI-ToF systems demonstrated accurate species-level identifications (91% and 90% agreement, respectively) compared to average nucleotide identity (ANI) analysis of WGS data. Distinct β-lactamase gene profiles were observed between BFSS and non-fragilis Bacteroides species, with significantly higher MICs to piperacillin-tazobactam in B. vulgatus and B. thetaiotaomicron relative to BFSS (P ≤ 0.034). We also uncovered phylogenetic diversity at the genomospecies level between division I and division II BFSS (ANI <0.95) and demonstrate that division II BFSS strains harbor an increased capacity to achieve carbapenem resistance through chromosomal activation of the CfiA carbapenemase. Finally, we report that CfiA detection by the Bruker BioTyper Subtyping Module accurately detected carbapenem resistance in BFSS with positive and negative percent agreement of 94%/90% and 95%/95% compared to ertapenem and meropenem susceptibility, respectively. These comparative analyses indicate that resistance mechanisms are distinct at both the phenotypic and genomic level across species within the BFG and that modern MALDI-ToF identification systems can be used for accurate species-level identification and resistance prediction of the BFG. American Society for Microbiology 2022-01-18 /pmc/articles/PMC8764542/ /pubmed/35038926 http://dx.doi.org/10.1128/mbio.03603-21 Text en Copyright © 2022 Wallace et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Wallace, Miranda J.
Jean, Sophonie
Wallace, Meghan A.
Burnham, Carey-Ann D.
Dantas, Gautam
Comparative Genomics of Bacteroides fragilis Group Isolates Reveals Species-Dependent Resistance Mechanisms and Validates Clinical Tools for Resistance Prediction
title Comparative Genomics of Bacteroides fragilis Group Isolates Reveals Species-Dependent Resistance Mechanisms and Validates Clinical Tools for Resistance Prediction
title_full Comparative Genomics of Bacteroides fragilis Group Isolates Reveals Species-Dependent Resistance Mechanisms and Validates Clinical Tools for Resistance Prediction
title_fullStr Comparative Genomics of Bacteroides fragilis Group Isolates Reveals Species-Dependent Resistance Mechanisms and Validates Clinical Tools for Resistance Prediction
title_full_unstemmed Comparative Genomics of Bacteroides fragilis Group Isolates Reveals Species-Dependent Resistance Mechanisms and Validates Clinical Tools for Resistance Prediction
title_short Comparative Genomics of Bacteroides fragilis Group Isolates Reveals Species-Dependent Resistance Mechanisms and Validates Clinical Tools for Resistance Prediction
title_sort comparative genomics of bacteroides fragilis group isolates reveals species-dependent resistance mechanisms and validates clinical tools for resistance prediction
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764542/
https://www.ncbi.nlm.nih.gov/pubmed/35038926
http://dx.doi.org/10.1128/mbio.03603-21
work_keys_str_mv AT wallacemirandaj comparativegenomicsofbacteroidesfragilisgroupisolatesrevealsspeciesdependentresistancemechanismsandvalidatesclinicaltoolsforresistanceprediction
AT jeansophonie comparativegenomicsofbacteroidesfragilisgroupisolatesrevealsspeciesdependentresistancemechanismsandvalidatesclinicaltoolsforresistanceprediction
AT wallacemeghana comparativegenomicsofbacteroidesfragilisgroupisolatesrevealsspeciesdependentresistancemechanismsandvalidatesclinicaltoolsforresistanceprediction
AT burnhamcareyannd comparativegenomicsofbacteroidesfragilisgroupisolatesrevealsspeciesdependentresistancemechanismsandvalidatesclinicaltoolsforresistanceprediction
AT dantasgautam comparativegenomicsofbacteroidesfragilisgroupisolatesrevealsspeciesdependentresistancemechanismsandvalidatesclinicaltoolsforresistanceprediction